Cabot (NYSE:CBT) Stock Rating Upgraded by StockNews.com

Cabot (NYSE:CBT) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Wednesday.

A number of other research firms also recently weighed in on CBT. UBS Group upped their price target on Cabot from $100.00 to $103.00 and gave the stock a “neutral” rating in a research report on Tuesday. Mizuho increased their target price on shares of Cabot from $104.00 to $109.00 and gave the stock a “buy” rating in a report on Tuesday. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Cabot from a “buy” rating to a “hold” rating and lifted their price target for the company from $88.00 to $95.00 in a research note on Thursday, April 18th. Three analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $93.67.

Cabot Stock Up 0.0 %

CBT stock traded up $0.01 during mid-day trading on Wednesday, hitting $101.08. 425,901 shares of the company were exchanged, compared to its average volume of 309,793. The firm has a market cap of $5.60 billion, a P/E ratio of 13.13, a P/E/G ratio of 1.00 and a beta of 1.27. Cabot has a 1-year low of $63.73 and a 1-year high of $103.46. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.30 and a current ratio of 2.04. The firm’s 50 day simple moving average is $91.52 and its 200 day simple moving average is $82.05.

Cabot (NYSE:CBT) last announced its earnings results on Monday, May 6th. The specialty chemicals company reported $1.78 earnings per share for the quarter, topping analysts’ consensus estimates of $1.66 by $0.12. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.04 billion. Cabot had a net margin of 11.24% and a return on equity of 25.52%. The company’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.33 EPS. On average, sell-side analysts predict that Cabot will post 6.58 EPS for the current fiscal year.

Insider Buying and Selling at Cabot

In other news, EVP Jeff Ji Zhu sold 55,233 shares of the business’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $79.91, for a total transaction of $4,413,669.03. Following the transaction, the executive vice president now directly owns 97,201 shares in the company, valued at approximately $7,767,331.91. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 3.07% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in CBT. EverSource Wealth Advisors LLC lifted its holdings in Cabot by 143.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 333 shares of the specialty chemicals company’s stock valued at $28,000 after purchasing an additional 196 shares during the last quarter. Arlington Trust Co LLC acquired a new stake in shares of Cabot during the 4th quarter worth about $34,000. Hexagon Capital Partners LLC boosted its holdings in shares of Cabot by 81.8% during the 4th quarter. Hexagon Capital Partners LLC now owns 460 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 207 shares during the period. SRS Capital Advisors Inc. grew its stake in Cabot by 372.0% in the 4th quarter. SRS Capital Advisors Inc. now owns 505 shares of the specialty chemicals company’s stock valued at $42,000 after buying an additional 398 shares during the last quarter. Finally, GAMMA Investing LLC bought a new position in Cabot in the 4th quarter valued at about $44,000. 93.18% of the stock is currently owned by institutional investors.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.